Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction [PDF]
World Journal of Surgical Oncology, 2012 Background The epidermal growth factor receptor (EGFR) inhibitor, gefitinib, has been reported to successfully treat advanced non-small cell lung cancer patients with genetic mutations in EGFR.
Wang Wen-Ping +3 more
doaj +2 more sources
Management of metastatic esophagogastric junction adenocarcinoma
Journal of Cancer Metastasis and Treatment, 2018 The prognosis of metastatic disease of esophagogastric junction adenocarcinoma remains poor, despite using a variety of regimens using cytotoxic agents.
Tasuku Toihata +3 more
openaire +3 more sources
Adenocarcinoma of the Esophagogastric Junction
, 2017 Esophagogastric junction (EGJ) cancer is, among solid cancers, the fastest growing tumor in terms of incidence in Western countries, and due to the lifestyle changes in developing and newly industrialized countries, this trend is expected to intensify worldwide.
GIACOPUZZI, Simone +2 more
openaire +3 more sources
Adenocarcinoma of the Esophagogastric Junction: Clinicopathological Characteristics [PDF]
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2012 The incidence of adenocarcinoma of the esophagogastric junction (AEG) is dramatically increasing in Western countries, while it is not increasing in Eastern countries.
김지현
openaire +2 more sources
Open Medicine, 2016 Although the Hox transcript antisense intergenic RNA (HOTAIR), a vital long non-coding RNA, is known to participate in the development and progression of a wide range of carcinomas, there are still no published reports regarding its expression in ...
Hui Zhang, Xianglin Meng
doaj +2 more sources
The study of molecular markers for the progression of Barrett's Oesophagus to adenocarcinoma to identify markers that can be used as diagnostic tools. [PDF]
, 2002 Barrett's oesophagus is a complication of gastro-oesophageal reflux disease and is the single most important predisposing factor for the development of adenocarcinoma of the oesophagus.
Cadd, Verity Anne
core +7 more sources
Molecular profiling of adenocarcinoma of esophagogastric junction.
Journal of Clinical Oncology, 2017 65 Background: Biologic understanding of adenocarcinoma of esophagogastric junction (AEJ) and similarity to gastric or esophageal adenocarcinoma has been long standing controversial issue, especially according to Siewert classification. The purpose of our study is to evaluate molecular characteristics of AEJ compared to esophageal (EAC) or upper ...
Yun-Suhk Suh +12 more
openaire +2 more sources
Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan [PDF]
Diseases of the Esophagus, 2002 Adenocarcinoma of the esophagogastric junction is recognized as a distinct clinical entity; however, the choice of surgical approaches is controversial. To analyze the results of surgery among patients with adenocarcinoma of the esophagus (type I) and the cardia (type II) based on Siewert's classification in Japan, surgical procedures, histopathologic ...
T, Nakamura +5 more
openaire +2 more sources
The esophagogastric junctional adenocarcinoma an increasing disease [PDF]
Journal of Thoracic Disease, 2017 Identifying and defining the esophagogastric junctional adenocarcinoma (EGJA) as an independent disease apart from gastric cancer (GC) and esophagus cancer (EG) it has always been a difficult issue entailing doubts about the appropriate therapeutic approach.
Pastina, Monica +3 more
openaire +3 more sources
Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]
, 2013 Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Klautke, Gunther +12 more
core +1 more source